PIK3CA and breast cancer: The animals that received DMBA administration showed PIK3CA gene mutations detected in all tumors, positively correlating with the activation of protein kinase B (AKT), and these genetic changes in the induced mammary tumors were similar to those that exist in natural mammary cancers [78].